Medical News
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer
New England Journal of Medicine - 17 Oct 2025 02:00
New England Journal of Medicine, Ahead of Print.
Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC
New England Journal of Medicine - 17 Oct 2025 02:00
New England Journal of Medicine, Ahead of Print.